GlassScriptPhysician profile
Juli D Taylor
NPI 1568544369
$1,458.94
in general payments reported to CMS, 2019-2025
24 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $584 · 2023: $398 · 2024: $166 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.40 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.19 | 2022-2023 | |
| Lilly USA, LLC | $76.35 | 2022-2023 | Mounjaro |
| Neurocrine Biosciences, INC. | $73.55 | 2022-2025 | Ingrezza |
| Novo Nordisk INC | $68.55 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $60.29 | 2022-2025 | Intellis Adaptivestim |
| Lundbeck LLC | $59.18 | 2024-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $58.27 | 2022-2023 | Rexulti |
| Abbott Laboratories | $52.08 | 2022-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $49.55 | 2022 | |
| Astellas Pharma US INC | $48.48 | 2023-2025 | Veozah |
| Amarin Pharma, INC. | $46.84 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $31.75 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.87 | 2022 | |
| Axsome Therapeutics, INC. | $29.67 | 2023 | Auvelity |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $27.92 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.56 | 2025 | Caplyta |
| Alnylam Pharmaceuticals INC. | $19.60 | 2023 | Onpattro |
| Glaxosmithkline, LLC. | $19.07 | 2024 | Bexsero, Arexvy, Shingrix |
| Amgen INC. | $18.15 | 2022 | |
| Phathom Pharmaceuticals, INC. | $16.33 | 2025 | Voquezna |
| Exact Sciences Corporation | $14.74 | 2024 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $14.72 | 2023 | Jornay Pm |
| Pfizer INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juli Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.